| Literature DB >> 34149784 |
Rachelle A Lapham1, Lan-Ying Lee1, Eder Xhako1, Esteban Gañán Gómez1,2, V M Nivya1,3, Stanton B Gelvin1.
Abstract
Agrobacterium effector protein VirE2 is important for plant transformation. VirE2 likely coats transferred DNA (T-DNA) in the plant cell and protects it from degradation. VirE2 localizes to the plant cytoplasm and interacts with several host proteins. Plant-expressed VirE2 can complement a virE2 mutant Agrobacterium strain to support transformation. We investigated whether VirE2 could facilitate transformation from a nuclear location by affixing to it a strong nuclear localization signal (NLS) sequence. Only cytoplasmic-, but not nuclear-localized, VirE2 could stimulate transformation. To investigate the ways VirE2 supports transformation, we generated transgenic Arabidopsis plants containing a virE2 gene under the control of an inducible promoter and performed RNA-seq and proteomic analyses before and after induction. Some differentially expressed plant genes were previously known to facilitate transformation. Knockout mutant lines of some other VirE2 differentially expressed genes showed altered transformation phenotypes. Levels of some proteins known to be important for transformation increased in response to VirE2 induction, but prior to or without induction of their corresponding mRNAs. Overexpression of some other genes whose proteins increased after VirE2 induction resulted in increased transformation susceptibility. We conclude that cytoplasmically localized VirE2 modulates both plant RNA and protein levels to facilitate transformation.Entities:
Keywords: Agrobacterium; Arabidopsis; VirE2; plant transformation; protein subcellular localization; proteome; transcriptome
Year: 2021 PMID: 34149784 PMCID: PMC8213393 DOI: 10.3389/fpls.2021.684192
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
FIGURE 1Subcellular localization of VirE2-Venus (A,B) and VirE2-Venus-NLS (C,D) in A. thaliana roots. Transgenic A. thaliana plants expressing inducible VirE2-Venus or VirE2-Venus-NLS were treated with β-estradiol (A,C) or control solution (B,D). Cerulean-NLS under the control of a CaMV 2 × 35S promoter was used to mark the nuclei. Root cells were imaged by confocal microscopy 9 h after treatment and representative images are shown. Four images of each cell are presented (left to right: Merged DIC + YFP + Cerulean; Cerulean; Venus; merged Venus + Cerulean). Boxes indicate an enlargement of one portion of the merged Venus + Cerulean image. Bars indicate 100 μm.
FIGURE 2Transformation susceptibility of Arabidopsis wild-type (Col-0) and β-estradiol inducible transgenic VirE2-Venus and VirE2-Venus-NLS plants. Agrobacterium-mediated transient transformation assays were conducted on roots of three transgenic lines of inducible VirE2-Venus, three transgenic lines of inducible VirE2-Venus-NLS, and wild-type Col-0 plants. Following treatment for 24 h with β-estradiol or control solutions, root segments were inoculated with (A) 108 cfu/mL of the virE2 mutant strain A. tumefaciens At1879 containing pBISN2 or (B) 105 cfu/mL of the wild-type VirE2 strain EHA105:pBISN1 (At1529). Root segments were stained with X-gluc 6 days after infection. Bars represent an average of three biological replicates (each replicate containing >60 root segments) + SE. ANOVA test *p-value < 0.05, **p-value < 0.01, ns, not significant.
VirE2 differentially expressed genes in both RNA-seq studies.
| Gene ID | Encoded Protein | Up/Down-regulated Second study (Fold-change) | Up/Down-regulated Pilot study (Fold-change) |
| VirE2 | Up (194.0)-3 h; Up (2342.3)-12 h | Up (188)-3 h; Up (1961.7)-12 h | |
| At1g01580 | Ferric reduction oxidase 2 | Down (2.5)-3 h; Down (2.4)-12 h | Down (1.4)-3 h; Down (2.5)-12 h |
| At1g09932 | Phosphoglycerate mutase family protein | Up (1.8) | Up (3.6) |
| At1g14200 | RING/U-box superfamily protein SNIPER1 | Up (3.4) | Up (1.9) |
| At1g23730 | Beta carbonic anhydrase 3 | Up (5.2) | Up (2.8) |
| At1g26800 | E3 ubiquitin-protein ligase MPSR1 | Up (3.0) | Up (1.4) |
| At1g32350 | Alternative oxidase 1D | Up (6.9) | Up (2.5) |
| At1g61560 | MILDEW RESISTANCE LOCUS O 6 | Up (1.9) | Up (1.7) |
| At1g61820 | Beta-glucosidase 46 | Up (1.9) | Up (1.8) |
| At1g62370 | RING/U-box superfamily protein | Up (2.5) | Up (1.9) |
| At1g63530 | Hypothetical protein | Up (3.0) | Up (1.5) |
| At1g66090 | Disease resistance protein (TIR-NBS class) | Up (4.6) | Up (6.3) |
| At1g73120 | F-box/RNI superfamily protein | Down (5.5) | Down (5.7) |
| At2g16660 | Major facilitator superfamily protein | Down (2.4) | Down (3.8) |
| At2g17040 | NAC domain containing protein 36 | Up (2.6) | Up (5.0) |
| At2g23270 | Transmembrane protein | Up (2.9) | Up (4.0) |
| At2g26150 | Heat stress transcription factor A-2 | Up (11.6) | Up (1.7) |
| At2g28160 | Transcription factor FER-LIKE IRON DEFICIENCY-INDUCED TRANSCRIPTION FACTOR | Up (1.8) | Up (1.4) |
| At2g29450 | Glutathione S-transferase tau 5 | Up (2.4) | Up (2.7) |
| At2g42850 | Cytochrome P450, family 718 | Up (2.1) | Up (1.4) |
| At2g44010 | Hypothetical protein | Up (1.6) | Up (3.2) |
| At2g44578 | RING/U-box superfamily protein | Up (2.9) | Up (1.6) |
| At2g45920 | U-box domain-containing protein | Up (1.9) | Up (1.4) |
| At3g07090 | PPPDE putative thiol peptidase family protein | Up (2.0) | Up (1.4) |
| At3g09290 | Telomerase activator1 (TAC1) | Up (3.2) | Up (2.2) |
| At3g09350 | Fes1A | Up (3.2) | Up (1.3) |
| At3g13437 | Enhancer of vascular Wilt Resistance 1; EWR1 | Up (2.2) | Up (3.6) |
| At3g14362 | DEVIL 19; DVL19; ROTUNDIFOLIA like 10 | Up (2.6) | Up (1.7) |
| At3g15340 | Proton pump interactor 2 (PPI2) | Up (2.8) | Up (1.3) |
| At3g29000 | Calcium-binding EF-hand family protein | Up (2.8) | Up (2.6) |
| At3g48920 | Myb domain protein 45 | Up (2.1) | Up (3.4) |
| At3g46810 | Cysteine/Histidine-rich C1 domain family protein | Down (2.7) | Down (2.7) |
| At3g53150 | UDP-glucosyl transferase 73D1 | Up (2.3) | Up (1.5) |
| At3g54150 | Embryonic abundant protein-like | Up (2.4) | Up (1.8) |
| At3g61400 | 1-aminocyclopropane-1-carboxylate oxidase homolog 8 | Down (9.7) | Down (2.7) |
| At4g04990 | Serine/arginine repetitive matrix-like protein (DUF761) | Up (2.1) | Up (2.4) |
| At4g19690 | Fe(2+) transport protein 1 | Down (2.5)-3 h; Down (2.8)-12 h | Down (2.3)-3 h |
| At4g26200 | 1-aminocyclopropane-1-carboxylate synthase 7 | Up (4.8) | Up (1.7) |
| At4g30230 | Uncharacterized protein At4g30230 | Up (26.2) | Up (2.1) |
| At4g30960 | CBL-interacting serine/threonine-protein kinase 6 | Up (1.6) | Up (1.4) |
| At4g33050 | Calmodulin-binding family protein | Up (1.9) | Up (1.3) |
| At4g34950 | Major facilitator superfamily protein | Down (2.3) | Down (3.7) |
| At4g37290 | Transmembrane protein | Up (5.1) | Up (5.7) |
| At4g39670 | ACD11 homolog protein | Up (2.1) | Up (1.5) |
| At5g02490 | Probable mediator of RNA polymerase II transcription subunit 37c | Up (2.3) | Up (2.8) |
| At5g03545 | Expressed in response to phosphate starvation protein | Down (1.6) | Down (2.3) |
| At5g06760 | LEA4-5 | Up (8.3)-3 h; Up (4.4)-12 h | Up (6.6)-12 h |
| At5g13320 | Auxin-responsive GH3 family protein | Up (8.3) | Up (27.3) |
| At5g25450 | Cytochrome b-c1 complex subunit 7 | Up (2.7) | Up (3.3) |
| At5g39050 | Phenolic glucoside malonyltransferase 1 | Up (2.4) | Up (1.4) |
| At5g39360 | EID1-like 2 | Up (1.7) | Up (1.5) |
| At5g39670 | Probable calcium-binding protein CML46 | Up (2.5) | Up (1.9) |
| At5g40010 | AAA-ATPase ASD, mitochondrial | Up (2.6) | Up (1.3) |
| At5g43450 | 1-aminocyclopropane-1-carboxylate oxidase homolog 10 | Up (3.9) | Up (3.4) |
| At5g45840 | Phytosulfokin receptor 1 | Up (2.5) | Up (1.3) |
| At5g51440 | 23.5 kDa heat shock protein, mitochondrial | Up (5.9) | Up (2.1) |
| At5g54165 | Avr9/Cf-9 rapidly elicited protein | Up (4.7) | Up (21.4) |
| At5g57010 | IQ domain-containing protein IQM5 | Up (5.4) | Up (1.6) |
| At5g57510 | Cotton fiber protein | Up (4.4) | Up (2.4) |
| At5g59820 | Zinc finger protein ZAT12 | Up (2.0) | Up (1.3) |
| At5g64810 | Probable WRKY transcription factor 51 | Up (3.0) | Up (1.7) |
FIGURE 3Gene Ontology (GO) Biological Process Categories of up- (A) and down-regulated (B) genes in the presence of VirE2. Displayed are categories of genes with 1.3-fold or greater change in expression, considering all time points.
FIGURE 4Gene Ontology (GO) Enrichment Analysis of VirE2 differentially expressed genes. GO biological processes of over-represented gene categories for VirE2 differentially expressed genes at all time points. Displayed are results only with a false discovery rate (FDR) < 0.05.
Transformation phenotypes of mutants of VirE2 differentially expressed genes.
| Gene Name | Gene_ID | Encoded Protein | Up/Down-regulated (Fold-change) | ABRC Stock ID | Transformation Result |
| At3g12965 | Long non-coding RNA | Up (5.8) | SALK_086573 | No change | |
| At3g44735 | Phytosulfokine 3 precursor | Up (5) | SALK_044781 | *Decreased transient | |
| At4g11280 | 1-aminocyclopropane-1-carboxylate synthase 6 | Up (3) | SALK_054467 | No change | |
| At5g66170 | Thiosulfate sulfurtransferase 18 | Up (3.7) | CS867285 | *Decreased transient and stable | |
| At1g75040 | Pathogenesis-related protein 5 | Up (14) | SALK_055063C | *Increased transient | |
| At5g56540 | Arabinogalactan protein 14 | Up (4.9) | SALK_096806 | No change | |
| At3g25795 | Up (15.1) | SALK_066997 | No change | ||
| At1g66725 | microRNA 163 | Up (3.3) | CS879797 | **Decreased stable | |
| At2g41380 | S-adenosyl-L-methionine-dependent methyltransferases superfamily protein | Up (10.1) | SALK_209995C | No change | |
| At3g17185 | Up (3) | GABI-Kat Stock N432182 (N2051875) | No change | ||
| At1g23720 | Proline-rich extensin-like family protein 1 | Down (3.3) | SALK_010243C | **Decreased stable | |
| At3g46330 | Maternal effect embryo arrest 39 (putative LRR receptor-like serine/threonine-protein kinase) | Down (4.7) | SALK_065070C | No change | |
| At5g38410 | Ribulose bisphosphate carboxylase small chain 3B | Down (7.4) | SALK_117835 | No change | |
| At5g45340 | Abscisic acid 8′-hydroxylase 3 | Down (3.4) | SALK_078170 | *Increased transient | |
| At3g45060 | High affinity nitrate transporter 2.6 | Down (28) | SALK_204101C | *Increased transient | |
| At3g60270 | Cupredoxin superfamily protein | Down (31.3) | SALK_201444C | **Increased transient | |
| At1g08090 | Nitrate transporter 2:1 | Down (35.7) | SALK_035429C | *Increased transient | |
| At3g63160 | Outer envelope protein 6 (chloroplast) | Down (5.6) | CS862774 | *Decreased stable | |
| At3g14210 | Epithiospecifier modifier 1 | Down (10) | SALK_150833C | **Increased stable | |
| At2g17850 | Rhodanese-like domain-containing protein 17 | Down (4.7) | SALK_115776C | ***Decreased transient and stable | |
| At2g30020 | Putative protein phosphatase 2C 25 | Down (3.5) | SALK_104445 | **Increased transient | |
| At1g77120 | Alcohol dehydrogenase 1 | Down (23.2) | SALK_052699 | ***Increased transient |
VirE2 subcellular localization impacts changes in plant gene expression.
| Gene Name | Gene_ID | Encoded Protein | Up/Down-Regulated in the presence of VirE2 (untagged) | Up/Down-regulated in the presence of VirE2-Venus (cytoplasmic) | Up/Down-regulated in the presence of VirE2-Venus-NLS (nuclear) |
| At1g01580 | FERRIC REDUCTION OXIDASE 2 | Down 2-fold | Down 2.9-fold | Up 6.3-fold | |
| At4g37290 | TRANSMEMBRANE PROTEIN | Up 5-fold | Up 3.9-fold | Down 6.9-fold | |
| At5g52640 | HEAT SHOCK PROTEIN 90-1 | Up 6-fold | Up 2.9-fold | Up 7.1-fold | |
| At5g06760 | LATE EMBRYOGENESIS ABUNDANT 4-5 | Up ≥3-fold | Up 1.6-fold | Down 2.5-fold | |
| At5g57010 | CALMODULIN-BINDING FAMILY PROTEIN | Up 5-fold | Up 6.1-fold | Up 4.0-fold |
FIGURE 5Quantitative RT-PCR analysis of selected VirE2 differentially expressed genes in inducible VirE2-Venus (cytoplasmic) versus inducible VirE2-Venus-NLS (nuclear) plants. VirE2-Venus (left) and VirE2-Venus-NLS (right) results of (A) FRO2, (B) TMP, (C) HSP90, (D) LEA4-5, and (E) CBFP gene expression in induced relative to non-induced roots. Bars represent an average of three technical replicates ± SE for one representative biological replicate of one transgenic line. Relative expression is shown after 3 (LEA4-5 only) or 12 h after induction in the presence of A. tumefaciens A136.
FIGURE 6Gene Ontology (GO) Biological Process Categories of VirE2 differentially expressed proteins. Proteins are grouped according to Gene Ontology (GO) process terms. Up-regulated proteins after 3 (A) or 12 (B) hours of VirE2 induction are shown along with down-regulated proteins after 3 (C) or 12 (D) hours of VirE2 induction. Only proteins which showed at least a 20% change in abundance for all three biological replicates determined by two different computational methods are shown. Total protein number is shown in the upper right corner of each graph and is highlighted in gray (up-regulated) or in black (down-regulated).
Proteins previously identified as important for transformation show increased abundance in the presence of VirE2.
| Gene ID | Gene Name | Encoded Protein | % Change in Protein Level (Time Post-VirE2 Induction) |
| At2g28740 | Histone H4 | +37% (3 h); | |
| At4g27230 | Histone H2A2 | +140% (3 h); | |
| At5g03740 | Histone deacetylase 2C | +35% (3 h); | |
| At3g44750 | Histone deacetylase 3 | +50% (12 h); | |
| At2g16600 | Rotamase cyclophilin 3 | +20% (12 h); | |
| At3g56070 | Rotamase cyclophilin 2 | +85% (12 h); | |
| At1g03870 | FASCICLIN-like arabinogalactan 9 | +25% (3 h); | |
| At1g28290 | Arabinogalactan protein 31 | +50% (3 h); |
Transformation phenotypes of A. thaliana lines containing overexpression constructs of genes whose proteins show increased abundance post-VirE2 induction.
| Gene ID | Gene Name | Encoded Protein | % Change in Protein Level (Time Post-VirE2 Induction) | Transformation Result |
| At3g49120 | Peroxidase 34 | +38% (3 h) | *Decreased stable | |
| At5g03740 | Histone deacetylase 2C | +35% (3 h) | **Increased transient and *Increased stable | |
| At3g44750 | Histone deacetylase 3 | +50% (12 h) | *Increased transient | |
| At3g56070 | Rotamase cyclophilin 2 | +85% (12 h) | **Increased transient | |
| At1g28290 | Arabinogalactan protein 31 | +50% (3 h) | *Increased transient |